|
⚲
|
| Keyboard |
| Firmani Lori
✚
|
|
|---|---|
| CIK # | 0001808248 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001808248] | |
| 4 | [0001808248] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Firmani Lori | |
| Damora Therapeutics Inc | |
| F-star Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Damora Therapeutics Inc GLTO
Common Stock
|
2026-01-02 | Sell | 135 | $21.41 | 2,890 |
|
Damora Therapeutics Inc GLTO
Common Stock
|
2026-01-02 | Option exercise | 374 | ||
|
Damora Therapeutics Inc GLTO
Restricted Stock Units · derivative
|
2026-01-02 | Option exercise | 374 | $0.00 | |
|
Damora Therapeutics Inc GLTO
Common Stock
|
2025-07-03 | Sell | 147 | $3.39 | 498 |
|
Damora Therapeutics Inc GLTO
Common Stock
|
2025-07-03 | Option exercise | 374 | ||
|
Damora Therapeutics Inc GLTO
Restricted Stock Units · derivative
|
2025-07-03 | Option exercise | 374 | $0.00 | |
|
Damora Therapeutics Inc GLTO
Restricted Stock Units · derivative
|
2025-01-03 | Option exercise | 726 | $0.00 | |
|
Damora Therapeutics Inc GLTO
Common Stock
|
2025-01-03 | Option exercise | 726 | ||
|
Damora Therapeutics Inc GLTO
Common Stock
|
2025-01-03 | Sell | 261 | $5.63 | 1,469 |
|
Damora Therapeutics Inc GLTO
Stock Option (right to buy) · derivative
|
2025-01-03 | Grant | 5,000 | $0.00 | |
|
Damora Therapeutics Inc GLTO
Stock Option (right to buy) · derivative
|
2024-10-09 | Grant | 13,000 | $0.00 | |
|
F-star Therapeutics Inc SBPH
Common Stock
|
2020-11-20 | Sell | 175 | $4.76 | 833 |
|
F-star Therapeutics Inc SBPH
Common Stock
|
2020-11-19 | Option exercise | 3,750 | ||
|
F-star Therapeutics Inc SBPH
Restricted Stock Units · derivative
|
2020-11-19 | Option exercise | 3,750 | $0.00 | |
|
F-star Therapeutics Inc SBPH
Common Stock
|
2020-11-19 | Grant | 12,500 |